BMRA (Biomerica) Current Deferred Taxes Liabilities: $ Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BMRA Biomerica Inc BMRA
46 GF Score
Price $2.66
GF Value $2.02
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Biomerica Current Deferred Taxes Liabilities?

Biomerica BMRA +2.31% 46 Current Deferred Taxes Liabilities is $ Mil as of May. 2026. GuruFocus rates BMRA with a GF Score™ of 46/100 and a GF Value™ of $2.02 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Biomerica's current deferred tax liabilities for the quarter that ended in May. 2026 was $ Mil.

Biomerica Current Deferred Taxes Liabilities Related Terms

Biomerica Current Deferred Taxes Liabilities Historical Data

* Premium members only.

The historical data trend for Biomerica's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomerica Current Deferred Taxes Liabilities Chart

Biomerica Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biomerica Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
BMRA
46GF Score
Biomerica Inc BMRA
Current Deferred Taxes Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Taxes Liabilities of $ Mil mean?
Biomerica (BMRA) has a Current Deferred Taxes Liabilities of $ Mil as of May. 2026. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Biomerica and its competitors.
Is Biomerica's Current Deferred Taxes Liabilities too high?
Biomerica's current Current Deferred Taxes Liabilities is $ Mil. Overall, Biomerica has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biomerica's Current Deferred Taxes Liabilities compare to VNRX and NXL?
Biomerica's Current Deferred Taxes Liabilities of $ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Taxes Liabilities for a Medical Devices & Instruments company?
A good Current Deferred Taxes Liabilities depends on the Medical Devices & Instruments industry context. However, Current Deferred Taxes Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Taxes Liabilities mean?
A high Current Deferred Taxes Liabilities can signal that a stock is expensive relative to its fundamentals. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Biomerica and its competitors. Biomerica's current Current Deferred Taxes Liabilities is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomerica stock overvalued right now?
Based on GuruFocus' analysis, Biomerica (BMRA) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.02, compared to a current price of $2.66 — trading 31.7% above its estimated fair value. The current Current Deferred Taxes Liabilities is $ Mil. Biomerica's overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Taxes Liabilities calculated?
Current Deferred Taxes Liabilities is calculated from a company's financial statements. For Biomerica (BMRA), the current Current Deferred Taxes Liabilities is $ Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biomerica (BMRA) Overvalued in 2026?

Based on GuruFocus' analysis, Biomerica stock appears to be overvalued. The current stock price of $2.66 is trading 31.7% above its estimated GF Value™ of $2.02. GuruFocus considers Biomerica to be Modestly Overvalued.

Key valuation signals for BMRA:

  • Current Deferred Taxes Liabilities: $ Mil
  • GF Value™: $2.02 vs. price of $2.66 (31.7% above fair value)
  • GF Score™: 46/100 with 7 warning signs

No single metric tells the full story. See the BMRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biomerica Business Description

Address 17571 Von Karman Avenue, Irvine, CA, USA, 92614
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
46GF Score

Get the complete analysis for BMRA

Current Deferred Taxes Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.66
Price
$2.02
GF Value